The study of gut microbiota modulation by elobixibat in chronic constipation

The study of gut microbiota modulation by elobixibat in chronic constipation - The study of gut microbiota modulation by elobixibat in chronic constipation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033259

Enrollment

Registered

2018-07-09

Start date

2018-07-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic constipation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients who are diagnosed chronic constipation by ROME criteria (2) Patients who can exhibit their consent in a document

Exclusion criteria

Exclusion criteria: (1) Patients who have severe complications (2) Patients who were administered elobixibat or antibiotics within 1 month (3) Patients who have history of elobixibat allergies (4) Patients who have bristol score 7 (5) Patients who have severe psychiatric disease (6) Patients who have current evidence of abuse of drugs or alcohol (7) Patients who or are going to take new medicines (8) Patients who or are going to be participating in other clinical studies (9) Patients who are judged as inadequately for study entry

Design outcomes

Primary

Measure	Time frame
Gut microbiota modulation from baseline to 2 weeks	—

Countries

Japan

Contacts

Public ContactNoboru Misawa

Yokohama City University school of medicine Department of gastroenterology and hepatology

misawa-ykh@umin.ac.jp045-787-2640

Outcome results